These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 21171719)
21. Innovation and the medical devices Farady partnership. Tavakoli M; Dunkerton SB Med Device Technol; 2005 Jun; 16(5):32-5. PubMed ID: 15984545 [TBL] [Abstract][Full Text] [Related]
22. South Korean biotechnology--a rising industrial and scientific powerhouse. Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684 [No Abstract] [Full Text] [Related]
23. The emergence of Egyptian biotechnology from generics. Abdelgafar B; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680 [No Abstract] [Full Text] [Related]
24. Global health public-private partnerships: IAVI, partnerships and capacity building. Hanlin R; Chataway J; Smith J Afr J Med Med Sci; 2007; 36 Suppl():69-75. PubMed ID: 17703568 [TBL] [Abstract][Full Text] [Related]
25. The future of clinical engineering: the challenge of change. Grimes SL IEEE Eng Med Biol Mag; 2003; 22(2):91-9. PubMed ID: 12733465 [TBL] [Abstract][Full Text] [Related]
26. Basic and applied research in India: present and future. Ramasami T; Rao AV; Natesh S Biotechnol J; 2009 Mar; 4(3):301-5. PubMed ID: 19296436 [No Abstract] [Full Text] [Related]
27. The scientific muscle of Brazil's health biotechnology. Ferrer M; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS Nat Biotechnol; 2004 Dec; 22 Suppl():DC8-12. PubMed ID: 15583686 [No Abstract] [Full Text] [Related]
28. Cuba--innovation through synergy. Thorsteinsdóttir H; Sáenz TW; Quach U; Daar AS; Singer PA Nat Biotechnol; 2004 Dec; 22 Suppl():DC19-24. PubMed ID: 15583679 [No Abstract] [Full Text] [Related]
29. Capital collaboration Washington DC. Russo E Nature; 2005 Feb; 433(7026):664-5. PubMed ID: 15703754 [No Abstract] [Full Text] [Related]
30. Changing university roles in the century of biotechnology. Meagher LR; Bolivar F Nat Biotechnol; 1998 Jul; 16(7):598-9. PubMed ID: 9661170 [No Abstract] [Full Text] [Related]
31. Research interactions between industry and academia: a corporate perspective. Citron P Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116 [No Abstract] [Full Text] [Related]
32. Straight talk with...Valery Danilenko. Interviewed by Gary Peach. Danilenko V Nat Med; 2011 Jul; 17(7):764. PubMed ID: 21738143 [TBL] [Abstract][Full Text] [Related]
33. Making green. Sheridan C Nat Biotechnol; 2009 Dec; 27(12):1074-6. PubMed ID: 20010574 [No Abstract] [Full Text] [Related]
35. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp]. Westerlund L Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544 [No Abstract] [Full Text] [Related]
36. [Conclusions of the conference]. Joly PB Med Sci (Paris); 2012; 28 Spec No 2():39-40. PubMed ID: 22759896 [No Abstract] [Full Text] [Related]
37. Technology transfer. Rutherford JJ IEEE Eng Med Biol Mag; 2010; 29(2):12-6. PubMed ID: 20659836 [TBL] [Abstract][Full Text] [Related]
39. The promise of South African biotech. Akermann B; Kermani F Drug Discov Today; 2006 Nov; 11(21-22):962-5. PubMed ID: 17055404 [No Abstract] [Full Text] [Related]